why choose us

First received: April 06, 2023

Clinical Trial: A Comparison of Extended Versus Conventional Duration of Enoxaparin Prophylaxis (i.e., Preventive Treatment) for Venous Thromboembolism (VTE, i.e., Blood Clots in the Veins) and Bleeding Event Risk in a Population With Acute Medical Illness

Study Status: ACTIVE_NOT_RECRUITING

Recruit Status: ACTIVE_NOT_RECRUITING

Condition: Venous Thromboembolism

Study Type: OBSERVATIONAL


Official Title: A Comparison of Extended Versus Conventional Duration of Enoxaparin Prophylaxis for VTE and Bleeding Event Risk in a Population With Acute Medical Illness

Brief Summary: Venous Thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), is associated with an increase in risk of mortality and long-term disability and is a major contributor to global disease burden.Participants hospitalized with an acute medical illness are at increased risk of VTE.This study a non-interventional study which analyzes data already collected in the Optum US clinical database.Its aim is to compare conventional versus extended duration prophylaxis with enoxaparin on the…

Read more